arrow_back Back to App

Condemning Biden Administration's Abortion Policies: Women's Health and Safety Concerns

This House Resolution condemns the Biden administration's policies regarding access to abortion medication, asserting they compromise the safety of women and girls. It highlights risks associated with a lack of medical oversight and the potential for misuse of the drugs against patients' will. The aim is to draw attention to potential health and safety threats for citizens.
Key points
The resolution condemns changes in the rules for dispensing mifepristone, an abortion medication, claiming they increase health risks for women.
It points to the removal of in-person doctor visit requirements and the allowance of mail-order dispensing, which could hinder the detection of complications like ectopic pregnancies.
It raises concerns that a lack of medical oversight might facilitate the misuse of the drug by third parties, for example, in cases of domestic abuse or human trafficking.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1285
Sponsor: Rep. Moran, Nathaniel [R-TX-1]
Process start date: 2024-06-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Condemning the pro-abortion policies of the Biden administration.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1285.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-06-07.

What are the main provisions?

Key points include:

  • The resolution condemns changes in the rules for dispensing mifepristone, an abortion medication, claiming they increase health risks for women.
  • It points to the removal of in-person doctor visit requirements and the allowance of mail-order dispensing, which could hinder the detection of complications like ectopic pregnancies.
  • It raises concerns that a lack of medical oversight might facilitate the misuse of the drug by third parties, for example, in cases of domestic abuse or human trafficking.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Moran, Nathaniel [R-TX-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health Family Courts and Law